A study evaluates the inclusion of Latin American patients and trial sites in pivotal phase 2 and 3 genitourinary and skin cancer research.

Experts strongly endorsed referral regardless of age, burden, or disease site, but emphasized cytoreduction before lymphodepletion.

Vanishing tumor occurred in 21% of patients, substantially delayed diagnosis, and independently predicted higher mortality.

A multisite, external validation study of men on prostate cancer active surveillance compared urinary MPS2-AS testing and mpMRI for upgrading.

Stage-specific EBV miRNA patterns may help distinguish early from advanced CLL and inform disease biology. EBV-encoded microRNAs (miRNAs) demonstrated distinct associations with clinical stage in ...

Investigators evaluated the efficacy and safety of immune checkpoint inhibitors in high-risk patients with genitourinary cancers and advanced chronic kidney disease.

In this observational study, researchers assessed the safety and efficacy of darolutamide with or without concomitant lipid-modifying agents in a clinical setting.

Researchers evaluated the long-term use of acalabrutinib monotherapy in patients with treatment-naïve or relapsed Waldenström macroglobulinemia.

The effects of PD-1 immune checkpoint inhibitors on therapy-related MDS are not well understood. Treatment with nivolumab for metastatic melanoma may have improved a concurrent case of therapy-related ...

Researchers assessed long-term outcomes of breast-conserving surgery for patients with multiple ipsilateral breast cancers.

Researchers evaluated a novel prognostic model incorporating molecular signatures for patients with secondary myelofibrosis.

Participants in the highest versus the lowest tertile of CDAI had significantly lower prevalence of cervical cancer.